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Abstract
Bone resorption in mice involves the degradation of extracellular matrix. Whereas several proteases seem to be implicated
in this process, it becomes increasingly clear that matrix metalloproteinases (MMPs), amongst them especially MMP-13 and
MMP-3, play an essential role. We have purified MMP-13 and MMP-3 from mouse calvariae-conditioned media by
differential fractionation and analyzed their collagenolytic, caseinolytic, gelatinolytic and proteoglycanolytic activities. It
could be shown that in mouse calvariae-conditioned media most of the measured enzyme activities were due to MMP-13,
although zymographies revealed that MMP-3, MMP-2, MMP-9 as well as TIMPs were present too. MMP-13 and MMP-3
proteins were detected and their enzyme activities were neutralized by specific polyclonal antisera. Furthermore, it was
demonstrated that in cultures of mouse calvariae the production of MMP-13 was induced by the potent MMP-stimulator
heparin and by parathyroid hormone (PTH), whereas the levels of MMP-3 remained unchanged. Although PTH-induced
bone resorption was inhibited by calcitonin treatment, MMP-13 mRNA and protein expression were not significantly altered
by this hormone. Together with previous observations, these results indicate that PTH regulates bone resorption through
MMP-13, but not by MMP-3, and that its reversion by calcitonin involves neither of the two enzymes. ß 1998 Elsevier
Science B.V. All rights reserved.
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1. Introduction
Bone resorption involves the removal of minerals
and the degradation of organic matrix constituents.
This physiopathological process requires the co-
operation between osteoblasts and osteoclasts and
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results in the secretion of lysosomal cysteine protei-
nases and of collagenase [1]. The rodent-type colla-
genase, collagenase-3 or MMP-13, belongs to the
family of matrix metalloproteinases (MMPs), a
group of endopeptidases together able to degrade
most of the structural protein constituents of the
extracellular matrix [2^4]. MMPs form a group of
zinc-dependent endopeptidases that share homolo-
gous protein sequences. They are active at neutral
pH in the presence of bivalent metal ions and are
inhibited by tissue inhibitors of metalloproteinases
(TIMPs). Secreted as proenzymes, they are activated
through limited proteolytic cleavage, which prob-
ably occurs by proteinases such as plasmin [5], stro-
melysin-1 [6] or by the recently discovered mem-
brane-type MMPs [7]. In vitro activation of the
latent enzymes can be achieved through cleavage
with trypsin or through induction of conformational
changes by reagents such as organomercurials or
detergents.
Among the MMPs, collagenases are exceptional in
their ability to degrade native collagen, the major
protein in the extracellular matrix, by cleaving its
triple helix into characteristic 1/4 and 3/4 fragments.
Furthermore, parathyroid hormone (PTH), a physio-
logical inducer of bone resorption, has been found to
stimulate MMP-13 protein in rodent bones with con-
sequences on the condition of extracellular matrix
[8]. Proteoglycans are another important constituent
of the extracellular matrix. MMP-3 is an enzyme
which not only cleaves the protein core of proteogly-
cans [9], but also is a potent activator of other
MMPs [6]. We have therefore puri¢ed MMP-13
and MMP-3 from mouse calvariae-conditioned me-
dia (CM) and analyzed the proteolytic activities of
both enzymes in collagenolytic, caseinolytic, gelati-
nolytic and proteoglycanolytic assays as well as in
gelatin and casein zymographies. Puri¢ed MMP-13
and MMP-3 were also used to raise speci¢c polyclo-
nal antisera adequate for the immunodetection of
mouse MMP-13 and MMP-3 protein by Western
blotting or ELISAs. We have then used mouse cal-
variae to study the e¡ect of various concentrations of
heparin, a potent MMP-stimulator, and of the phys-
iological hormone PTH on MMP-13 and MMP-3
gene and protein expression.
Part of this work has been presented as prelimi-
nary communication [10].
2. Materials and methods
2.1. Materials
Mouse MMP-13 [11] and MMP-3 [12] cDNAs,
cloned into pBluescript KS, were a gift of Dr. Y.
Eeckhout. Puri¢ed bovine TIMP was a gift of Drs.
T. Cartwright and D. Faucher (Rho“ne Poulenc
Sante¤, Vitry-sur-Seine, France). NMRI (Naval Med-
ical Research Institute) mice derived from the UCL
animal house (Brussels, Belgium). Polyclonal antisera
were raised in goats at the Centre d’Economie Rurale
(Marloie, Belgium). Manufacturers for speci¢c re-
agents and equipment are listed hereafter. Ambion
(Austin, TX, USA): mouse GAPDH cDNA. Amer-
sham (Little Chalfont, UK): biotinylated donkey
anti-goat IgGs and biotinylated peroxidase streptavi-
din complex. Amicon (Beverly, MA, USA): PM 10
and PM 30 Dia£o Ultra¢lters, Centricon and Cen-
triprep concentrators. Bachem (Bubendorf, Switzer-
land): bovine parathyroid hormone (1^34). Bio-Rad
(Hercules, CA, USA): molecular weight standards
and Prep Cell model 491. Boehringer (Mannheim,
Germany): streptavidin-L-galactosidase and methyl-
umbelliferyl-L-galactopyranoside. Gibco-BRL (Pais-
ley, UK): basal medium (Eagle), Medium 199.
Nunc (Roskilde, Denmark): £at and conical bottom
microtiter plates, ELISA plates and culture material.
Pharmacia (Uppsala, Sweden): DEAE Sepharose
CL-6B, heparin^Sepharose CL-6B, chelating Sephar-
ose 6B and PD10 column. Promega (Madison, WI,
USA): in vitro transcription kit. Sigma (St. Louis,
MO, USA): APMA, salmon calcitonin, £uores-
camin, heparin, indomethacin and N-hydroxysucci-
midobiotin. Worthington (Freehold, NJ, USA):
trypsin and soybean trypsin inhibitor. All other re-
agents were analytical grade chemicals from Sigma
(St. Louis, MO, USA) or Merck (Darmstadt, Ger-
many).
2.2. Bone organ cultures
Frontal and parietal calvariae of 4^5-day-old
NMRI mouse were maintained in serum-free basal
Eagle’s medium (1 ml/calvarium), supplemented with
100 U/ml penicillin and 78 U/ml streptomycin, at 5%
CO2 for 1^4 days at 37‡C either in the absence or
presence of 300 Wg/ml heparin as previously de-
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scribed [13]. Conditioned media were then collected,
centrifuged, stabilized by 5 mM CaCl2, 0.05% Triton
X-100 and 0.02% azide in either 50 mM Tris-HCl pH
7.5 or 50 mM cacodylate pH 7 bu¡er, and frozen. In
the PTH-induced bone resorption experiments, cal-
variae were maintained in the absence or presence of
PTH in serum-free Medium 199 (2 ml/calvarium),
supplemented with 5 Wg/ml indomethacin, 200 Wg/
ml glutamine and 30 Wg/ml ascorbic acid, for 6^72 h
at 37‡C as previously described [8]. PTH-induced
bone resorption was inhibited by addition of 0.9 U/
ml calcitonin. Calvarial MMPs were extracted as pre-
viously described [14] and Ca2 release into the me-
dium was measured by atomic absorption spectro-
photometry.
2.3. Culture medium fractionation
Two hundred to 500 ml of mouse calvariae-condi-
tioned media, produced in the presence of 300 Wg/ml
heparin for 4 days, was fractionated as described
below. The puri¢cation processes represent a ¢nal
development of previously described procedures
[15,16]. The media were ¢rst concentrated 10U on
an Amicon PM 10 or PM 30 membrane, dialyzed
twice against 10 vol of CCBT (50 mM Na-cacodylate
bu¡er pH 7 containing 5 mM CaCl2, 0.05% Brij-35
and 0.03% toluol) and centrifuged for 20 min at
41 000Ug. The supernatants were applied on a
DEAE Sepharose CL-6B column (15U1.6 cm), pre-
viously equilibrated with CCBT. The £ow through
medium was fraction C1. The column was rinsed
with 60 ml CCBT yielding fraction C2. To purify
MMP-13, the DEAE Sepharose CL-6B column was
¢rst washed with 60 ml of 0.1 M NaCl CCBT (frac-
tion C3). Fraction C4 was obtained by eluting with
60 ml 0.2 M NaCl CCBT and by a subsequent pas-
sage through a heparin^Sepharose CL-6B column
(20U1.6 cm) previously equilibrated with 0.1 M
NaCl CCBT. A rinse with 80 ml of 0.6 M NaCl
CCBT yielded fraction C5. The column was then
eluted with 80 ml 1 M NaCl CCBT and the eluate
was passed through a chelating Sepharose 6B column
(5U1.6 cm) previously saturated with ZnCl2 and
equilibrated with 0.6 M CBBT: the £ow through
was fraction C6. The column was then eluted with
48 ml of 1 M NaCl CCBT containing 50 mM imi-
dazole; the resulting eluate was fractionated in 6 ml
fractions (fractions C7^C15). MMP-3 was puri¢ed
from fractions C1 and C2. Both fractions were com-
bined and applied to a heparin^Sepharose CL-6B
column (8U2.6 cm) previously equilibrated with
CCBT; the £ow through eluate was termed fraction
S1. The column was rinsed with 90 ml of CCBT
(fraction S2), then with 90 ml 0.1 M NaCl CCBT
(fraction S3), and subsequently eluted with 120 ml
CCBT 0.2 M NaCl. A further passage through a
chelating Sepharose 6B column (10U1 cm), previ-
ously saturated with ZnCl2 and equilibrated with
0.1 M NaCl CCBT, resulted in fraction S4. Finally,
the column was eluted with 0.2 M NaCl CCBT con-
taining 50 mM imidazole, and the eluate was sepa-
rated in 6 ml fractions (fractions S5^S10). The puri-
¢cation steps are schematized in Fig. 1. All
chromatographic procedures were carried out at
4‡C at a £ow rate of 18 ml/min. When the initial
sample was applied on the DEAE Sepharose CL-
6B column and when eluates were passed through
two columns the £ow rate was reduced to 7.2 ml/
min. Protein concentrations were measured with £u-
orescamin [17].
2.4. Enzyme assays
Total lytic activities were measured on collagen,
casein and gelatin after activation by 0.25^0.4 mM
APMA for 2 h at 25‡C, or by 2.5^10 Wg/ml trypsin
for 10 min at 25‡C, or at 37‡C where indicated, as
previously described [18]. Collagenolytic activities
were measured by incubating the samples with 3H-
acetylated acid-soluble guinea pig skin or rat tail
collagen at 25‡C in a soluble collagen assay [18] or
at 35‡C in a di¡use-¢bril assay [19]. Caseinolytic ac-
tivities were assayed by incubating the samples with
3H-methylated casein at 37‡C [20] and gelatinolytic
activities by incubating them with 3H-acetylated gel-
atin at 25‡C [21]. In all assays, 1 U corresponded to
the amount of enzyme that degrades 1 Wg of sub-
strate per minute. Proteoglycanolytic activities were
measured by the ability to degrade [3H]proteoglycan
aggregates (PGCs) as previously described [22]. Al-
ternatively, [3H]PGCs, equivalent to 3.75 mg/ml ur-
onic acid in 5 mM Tris-HCl pH 7.5, were copoly-
merised with 5% acrylamide between two mini gel
glass plates and 5 mm diameter 0.75 mm thick discs
were punched out of the gel. The discs were rinsed
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four times with 0.15 M NaCl, 0.02% azide. To
measure proteoglycanolytic activity, each disc was
incubated with the sample under mild agitation in
a total volume 100 Wl of 50 mM Tris-HCl pH 7.5,
5 mM CaCl2, 0.1 M NaCl, 0.05% Triton X-100,
0.02% azide for up to 9 h at 37‡C. Under these con-
ditions, PGCs degradation was linear in function of
time and logarithmic in function of sample concen-
tration for at least 9 h of incubation and for up to
40% of substrate degradation (data not shown). One
unit was de¢ned as the amount of enzyme degrading
10% of substrate in 1 h.
2.5. Zymographies and preparative electrophoresis
Gelatin, casein and reverse (gelatin) zymographies
were performed as described elsewhere [21], except
that mouse calvariae-conditioned culture medium
was used in the overnight reverse (gelatin) zymo-
graphies incubation bu¡er. The samples analyzed
in reverse zymographies were 10U more concen-
trated than in the corresponding zymographies.
Where indicated, zymographies were carried out
under reducing conditions by addition of 50 mM
DTT in the loading bu¡er. Preparative electrophore-
sis was performed by using a Prep Cell with 20 ml of
10% polyacrylamide separating gel and 5 ml of 4%
polyacrylamide stacking gel. The elution bu¡er was
SDS-free and £ow rate was 18 ml/min. Fractions
containing either pure MMP-13 or MMP-3 were
combined and, in order to eliminate the contaminat-
ing SDS, were dialyzed 3U against 5 mM Tris-HCl
bu¡er pH 7.5 containing 0.005% Triton X-100 and
0.03% toluol and 3U against PBS containing 0.05%
Brij-35. The dialysate was concentrated in a Centri-
pep.
2.6. Production, puri¢cation and labeling of
antibodies
Polyclonal sera against mouse MMP-13 or MMP-
3 were produced by immunizing goats with 50^100
Wg of the puri¢ed proteins obtained by Prep Cell
electrophoresis. IgGs were puri¢ed by combined Ri-
vanol fractionation [23] and ammonium sulfate frac-
tionation. Protein concentrations were measured ac-
cording to Lowry [24]. N-Hydroxysuccimidobiotin
was used to biotin label the IgGs [25].
2.7. Western blotting
Samples were concentrated 10U with a Centricon
and subjected to Western blotting [26] after SDS-
polyacrylamide gel electrophoresis under non-reduc-
ing conditions. PBS containing 5% skimmed milk
powder, 0.05% Tween-20 and 0.02% azide was used
as blocking solution. The washing bu¡er was PBS,
0.05% skimmed milk powder, 0.05% Tween-80,
0.02% azide. Amounts of 0.5^10 Wg/ml of anti-mouse
MMP-13 or anti-mouse MMP-3 IgGs were used as
primary antibody. Immune complexes were detected
by biotinylated donkey anti-goat IgGs. The second-
ary antibodies were visualized by using a biotinylated
peroxidase streptavidin complex with 4-chloro-1-
naphthol as substrate according to the manufactur-
er’s instructions.
2.8. ELISAs
Direct competitive ELISAs were developed for to-
tal MMP-3 and MMP-13. For the MMP-3 ELISAs,
96-well microtiter plates were coated with 100 Wl of
fractions C1+C2 adjusted to 0.6 Wg/ml total protein
in PBS. For the MMP-13 ELISAs, a fraction C4 was
used that had been passed through a PBS, 0.02%
azide equilibrated PD10 column, instead of a hepa-
rin^Sepharose CL-6B column, to eliminate interfer-
ing Brij-35; microtiter plates were coated with 100 Wl
of 2 Wg/ml total protein eluate. The coated plates
were left overnight at 4‡C and washed 3U with the
washing solution (PBS, 0.5% skimmed milk powder,
1 mM EDTA, 0.05% Tween-80, 0.02% azide). The
protein binding sites were then saturated with 100 Wl
of PBS, containing 5% skimmed milk powder, 1 mM
EDTA, 0.05% Tween-80 and 0.02% azide, for 1 h at
35‡C, and rinsed 3U. Samples and standards were
treated with 0.4 mM APMA for 2 h at 25‡C and
serial dilutions were incubated for 2 h at 35‡C with
an equal volume of either 10 Wg/ml biotinylated anti-
mouse MMP-13 IgGs or 20 Wg/ml biotinylated anti-
mouse MMP-3 IgGs; 100 Wl was added per well and
incubated for 2 h at 25‡C. After three washes, 100 Wl
of 1/2000 streptavidin-L-galactosidase was added per
well and the plates were incubated for 1 h at 35‡C.
After another washing cycle, 100 Wl of 10 mM
K-phosphate bu¡er pH 7, containing 0.3 mM meth-
ylumbelliferyl-L-galactopyranoside, 0.15 M NaCl,
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2 mM MgCl2 and 0.1% BSA, was added and the
plates were incubated at 35‡C. Resulting £uorescence
was measured by a Cyto£uor £uorimeter after di¡er-
ent time intervals for up to 1 h. Under these condi-
tions, both immunoassays were capable of detecting
at least 4 ng of enzyme and were not in£uenced by
the presence of TIMPs (data not shown).
2.9. RNA extraction and RNase protection assay
Total RNA was extracted from frozen calvariae as
previously described [27]. The quantity of total
RNAs was determined by spectrophotometry and
quality was assessed by denaturing gel electrophore-
sis. MMP-13 and MMP-3 mRNAs were detected by
RNase protection assays [28]. 32P-Labeled probes
were synthesized by in vitro transcription from
MMP-13 and MMP-3 cDNA templates according
to the manufacturer instructions. An amount of 20
Wg of total RNA was hybridized to the probe and
subjected to RNase protection assays as previously
described [29]. Mouse GAPDH was used as loading
control. Probably due to incomplete in vitro tran-
scription of the MMP-3 cDNA, speci¢c hybridiza-
tion to mRNA resulted in a ‘ladder-type’ appearance
of the protected fragment. Hybridization of MMP-3
alone con¢rmed that the ladder represented a speci¢c
signal (data not shown). The gels were scanned on an
Apple color scanner using Ofoto software and the
images analysis were performed using NIH Image
1.62.
3. Results and discussion
3.1. Puri¢cation of mouse MMP-13 and MMP-3
Puri¢cation of MMP-13 or of MMP-3 was per-
formed as described in Section 2. The progressive
enrichment of the fractions in MMP-13 or MMP-3
was assessed by collagenolytic, caseinolytic, gelatino-
lytic and proteoglycanolytic assays after APMA or
trypsin activation, and by gelatin and casein zymog-
raphies. TIMPs were detected by reverse (gelatin)
zymography.
The results of the fractionation of conditioned me-
dia are shown in Fig. 2. The vast majority of proteins
(94%) was eliminated in fractions C1^C6 (Fig. 2A).
Although fractions 9 and 10 contained only 4% of
the total protein in conditioned medium, they repre-
sented more than 90% of the overall collagenolytic
activity (Fig. 2B after APMA activation, Fig. 2C
after trypsin activation). Caseinolytic (Fig. 2E) and
gelatinolytic (Fig. 2G) activity pro¢les after trypsin
activation corresponded well with the collagenolytic
activity pro¢le. However, after APMA activation,
but not after trypsin activation, caseinolytic activity
was detected in fraction C2 (Fig. 2D) and gelatino-
lytic activity in fraction C3 (Fig. 2F). Whereas the
source of the caseinolytic activity in C2 was not yet
identi¢ed here, gelatinolytic activity of fraction C3
probably contained MMP-2, which degrades gelatin
and is only activatable by APMA, but not by trypsin
[30]. The caseinolytic activity after APMA activation
(Fig. 2D) had the same pro¢le as the proteoglycano-
Fig. 1. Schematic presentation of the chromatographic condi-
tions used to fractionate mouse calvariae-conditioned media.
CCBT = 50 mM Na-cacodylate bu¡er pH 7 containing 5 mM
CaCl2, 0.05% Brij-35 and 0.03% toluol; DEAE Seph = DEAE
Sepharose; HEP Seph = heparin Sepharose; ZnCh Seph = Zn2-
saturated chelating Sepharose.
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lytic activity after APMA activation (data not
shown), suggesting that the proteins present in C2
and C9+C10 have proteoglycanolytic and caseino-
lytic activities alike.
Zymographic analysis of fractions C1^C14 is
shown in Fig. 3. Gelatinolytic activity of the condi-
tioned medium (CM) was mainly recovered in frac-
tion C3 at 68 and 62 kDa, corresponding to the un-
reduced state of latent and active MMP-2 [31], and
in fraction C5 at 92 kDa, corresponding to MMP-9
(Fig. 3A). MMP-13 was mainly present in fractions
C9 and C10 and appeared as two doublets in the
gelatin zymography. The upper doublet of 61 and
55 kDa corresponded to the latent enzyme and the
lower one of 46 and 40 kDa was caused by the active
enzyme. Each doublet was present in the glycosylated
and the non-glycosylated forms. Due to their close
molecular weights, the more luminous MMP-2 dou-
blet overlapped the latent MMP-13 doublet in the
gelatin zymographies of the unfractionated media
(CM). However, when 50 mM DTT was added to
the loading bu¡er, the MMP-2, MMP-9 and TIMP
signals disappeared thus allowing for enhanced visu-
alization of MMP-13 activity (Fig. 3B). This speci¢c
e¡ect of DTT on MMP-2 and MMP-9, but not on
MMP-13, suggests the existence of disul¢de bridge(s)
in the cysteine-rich ¢bronectin-like domain which is
exclusively present in gelatinase molecules and is re-
sponsible for their binding to gelatin. Fig. 3C shows
that caseinolytic activity was present in fractions C2,
C9 and C10. The activity pro¢les in fractions C9 and
C10 were identical with the two doublets seen in the
gelatin zymographies in Fig. 3A,B. They also corre-
lated with the pro¢les observed for C9 and C10 in
Fig. 2D,E, suggesting that MMP-13 has caseinolytic
activity. The reverse (gelatin) zymographies indicate
that TIMPs were present in fractions C2 and C3, and
as traces also in fractions C9 and C10 (Fig. 3D).
Overall, the fractionation of mouse calvariae-con-
ditioned media revealed that MMP-13 accounted for
all the collagenolytic activity and for most of the
caseinolytic and gelatinolytic activities measured in
this tissue. The discrepancy observed for the MMP-
2 containing C3 fraction between its relatively low
gelatinolytic activity measured in the enzyme assay
(Fig. 2F) and its strong signal observed on the gela-
tin zymography (Fig. 3A) is likely to be due to the
presence of TIMPs.
In Fig. 3C a band of 57 kDa was observed in
fraction C2 and, although inconsistently, in fraction
C1. Since the size of mouse MMP-3 is 57 kDa and
since MMP-3 is known to posses proteoglycanolytic
Fig. 2. Fractionation of mouse calvariae-conditioned media.
Two hundred mouse calvariae were maintained in basal Eagle’s
medium for 4 days in the presence of 300 Wg/ml heparin. The
resulting conditioned media were concentrated 10U and fractio-
nated according to the schema in Fig. 1. Enzyme activities were
measured in collagenolytic (B,C), caseinolytic (D,E), and gelati-
nolytic (F,G) assays, after activation with either 0.4 mM
APMA for 2 h at 25‡C (B,D,F), or 5 Wg/ml trypsin for 10 min
at 25‡C (C,E,G). Protein content (A) and enzyme activities
(B^G) in fractions C1^C14 are presented as percent of the sum
recovered in fractions C1^C14. 100% = 9.47 mg in A, 709 U in
B, 1348 U in C, 219 U in D, 428 U in E, 1223 U in F and
1962 U in G.
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activity, fractions C1 and C2 were combined and
provided the starting material for the MMP-3 puri-
¢cation. The resulting fractions S1^S10 were sub-
jected to caseinolytic and proteoglycanolytic assays
(Fig. 4). Whereas 90% of the proteins of the starting
material was eluted in S1^S3 (Fig. 4D), most casein-
olytic activity (Fig. 4A after APMA activation, Fig.
4B after trypsin activation) and proteoglycanolytic
activity (Fig. 4C) were recovered in fraction S8. No
signi¢cant collagenolytic or gelatinolytic activities
were detected in any of the fractions (data not
shown).
Fractions S1^S10 were then subjected to gelatin,
casein and reverse (gelatin) zymographies to further
characterize the enzyme activities present (Fig. 5). In
fraction S8, a strong single band of gelatinolytic (Fig.
5A) and caseinolytic (Fig. 5B) activities was visible at
approximately 57 kDa, thus corresponding to MMP-
3. It is also likely that MMP-3 was responsible for
the strong caseinolytic and proteoglycanolytic activ-
ities of fraction S8 in Fig. 4A^C. Furthermore, a
band of 51 kDa was visible in fractions S1 and S2
on the gelatin and casein zymographies whose iden-
tity is not clear. The reverse (gelatin) zymography in
Fig. 5C shows that the bulk of TIMPs had already
been eliminated from the S fractions by the passage
through the heparin^Sepharose column.
Although the puri¢ed MMP-13 and MMP-3 ap-
peared pure as judged by silver-stained SDS-PAGE
(data not shown), reversed (gelatin) zymographies
still showed contamination with traces of TIMPs
(Fig. 3D, C9 and C10, and Fig. 5C, S8). These pro-
Fig. 3. Zymographic analysis of mouse calvariae-conditioned media. Unfractionated mouse calvariae-conditioned media (CM) and
fractions C1^C14 were subjected to SDS-polyacrylamide electrophoresis containing gelatin (A,B,D) or casein (C). Prior to migration,
1 vol. of loading bu¡er without (A,C,D) or with 50 mM DTT (B) was added and 15 Wl was loaded onto the gel. Reverse (gelatin)
zymographies are shown in D. St = molecular weight standards.
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teins were eliminated from the end products by con-
tinuous elution electrophoresis with the ‘Prep Cell’.
Fig. 6 shows a representative reverse (gelatin) zymog-
raphy of fractions C9+C10 and subsequent fractions
in which residual TIMPs were progressively elimi-
nated. TIMPs appeared in fractions 24^29, whereas
MMP-13 was present in fractions 32^55 (only critical
fractions 24^35 are shown). TIMPs were eliminated
from the puri¢ed MMP-3 fraction (S8) by using the
same procedure (data not shown).
3.2. Characterization of polyclonal sera against
MMP-13 and MMP-3
The highly puri¢ed and TIMP-depleted MMP-13
and MMP-3 fractions were used to raise polyclonal
antisera as detailed in Section 2. Fig. 7 shows a
Western blot where conditioned medium, puri¢ed
MMP-13 and puri¢ed MMP-3 were subjected to
Western blotting and incubated with either anti-
mouse MMP-13 or anti-mouse MMP-3 IgGs. Both
IgGs preparations reacted with MMP-13 and MMP-
3 present in the conditioned medium (CM), and each
IgGs preparation detected only the puri¢ed MMP
they had been raised against. No cross reactivity
was observed and no bands at the size of TIMP-1
or TIMP-2 (21 and 28 kDa) were visible. Whereas
the addition of anti-mouse MMP-13 IgGs to condi-
tioned medium resulted in one double band, incuba-
tion with puri¢ed MMP-13 yielded two doublets and
a band at 25 kDa, suggesting that MMP-13 had been
partly autoactivated during the puri¢cation process
and with time. Furthermore, neither anti-mouse
MMP-13 nor anti-mouse MMP-3 IgGs crossreacted
with partially puri¢ed mouse fractions of TIMPs or
Fig. 5. Zymographic analysis of fractions S1^S9. Mouse calvar-
iae-conditioned medium (CM), fractions C1+C2 and the S frac-
tions were submitted to SDS-polyacrylamide electrophoresis
containing gelatin (A,C) or casein (B). Fractions S1^S4, S8 and
S9 are shown. Samples were diluted with 1 vol. of loading bu¡-
er without DTT. Reverse (gelatin) zymography is shown in C.
St = molecular weight standards.
Fig. 4. Caseinolytic and proteoglycanolytic activities of MMP-3
enriched fractions. Four hundred and twenty-six mouse calva-
riae were maintained in basal Eagle’s medium for 4 days in the
presence of 300 Wg/ml heparin. The resulting conditioned media
were concentrated 10U and fractionated according to the sche-
ma in Fig. 1. Fractions C1 and C2 were combined and further
processed to purify MMP-13. Enzyme activities (A^C) and pro-
tein content (D) in fractions S1^S10 are presented in percent of
the sum recovered in the fractions S1^S9. Caseinolytic (A,B)
and proteoglycanolytic (C) activities were measured after activa-
tion by 0.25 mM APMA for 2 h at 25‡C (A,C) or by 5 Wg/ml
trypsin for 10 min at 37‡C (B). Proteoglycanolytic activities
were measured on PGCs entrapped in polyacrylamide discs as
described in Section 2. 100% = 226 U in A, 304 U in B, 36.1 U
in C and 2.62 mg in D.
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MMP-2 (data not shown). The capacity of the anti-
sera to neutralize the enzymatic activities of MMP-13
and MMP-3 was veri¢ed by immunoinhibition and
immunoprecipitation experiments (data not shown).
3.3. Heparin di¡erentially regulates MMP-13 and
MMP-3 expression in mouse calvariae-
conditioned medium
Heparin is a potent inducer of MMP-13 produc-
tion by mouse bones in vitro [13]. To investigate the
regulation of MMP-13 and MMP-3 expression,
mouse calvariae were cultured in the absence or pres-
ence of increasing concentration of heparin for 2 or 4
days (Fig. 8). Gelatin zymographies performed on
conditioned media show that in the absence of hep-
arin the 46 and 40 kDa forms of MMP-13 were un-
detectable but appeared when 33^300 Wg/ml heparin
was present in the culture media (Fig. 8A). Con-
versely, the 68 and 62 kDa forms of MMP-2 and
92 kDa MMP-9 were already present in untreated
media and remained unchanged upon the addition
of heparin (Fig. 8A). Fig. 8B shows that the 57
and 60 kDa MMP-3 casein activities remained essen-
tially unchanged when heparin was added to the cul-
tures. Under the same experimental conditions, the
secretion of TIMPs was similarly not a¡ected by the
presence of heparin (Fig. 8C). The di¡erential expres-
sion pattern of MMP-13 and MMP-3 was even more
evident in Western blots (Fig. 8D): whereas in the
absence of heparin MMP-13 was not detectable in
medium conditioned for 2 days, a faint signal was
observed after 4 days. Addition of increasing concen-
tration of heparin considerably augmented the sig-
nals. By contrast, MMP-3 was already immunode-
tected in untreated medium after 2 days and was
not markedly altered by heparin addition (Fig. 8E).
The results of Western blots were furthermore con-
¢rmed by MMP-3 ELISAs, in which the protein
amounts remained similarly unchanged regardless
whether heparin was present or not, and whether
calvariae were cultured for 24 or 48 h. By contrast,
MMP-13 markedly augmented upon addition of hep-
arin (Table 1).
To investigate MMP-13 and MMP-3 mRNA ex-
pression in response to heparin, RNase protection
assays were performed on total RNAs from mouse
calvariae that had been treated without or with 300
Wg/ml heparin for 6^24 h. Whereas MMP-3 mRNA
levels were equal in untreated and treated calvariae,
MMP-13 mRNA expression was considerably upre-
gulated in the presence of heparin after 24 h. How-
ever, in the absence of heparin MMP-13 mRNA ap-
peared to increase at 24 h when compared to 6 h
(Fig. 8F).
Fig. 7. Speci¢city of the anti-mouse MMP-13 and anti-mouse
MMP-3 IgGs. 10U concentrated mouse calvariae-conditioned
medium (CM), fractions C9, containing puri¢ed MMP-13, and
fraction S8, containing puri¢ed MMP-3, were subjected to
Western blotting and incubated with either 2.5 Wg/ml anti-
mouse MMP-13 IgGs (-13) or 0.6 Wg/ml anti-mouse MMP-3
IgGs (-3). St = molecular weight standards.
Fig. 6. Elimination of contaminating TIMPs by continuous elu-
tion electrophoresis. MMP-13 enriched fractions C9 (4 ml) and
C10 (2 ml) were combined, concentrated 5U and diluted with
1 vol. loading bu¡er. An amount of 2 ml, containing 560 Wg
total proteins, was then layered onto a SDS-polyacrylamide col-
umn as detailed in Section 2. About 100 fractions of 3 ml each
were collected. Fractions eluted before the loading bu¡er dye
were discarded. Subsequent fractions were paired and analyzed
by reverse (gelatin) zymography. Fractions 24^35 are shown.
St = molecular weight standards.
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3.4. PTH stimulates MMP-13, but not MMP-3,
mRNA and protein expression in mouse calvariae
extracts
PTH is a physiological inducer of bone resorption
and has previously been shown to stimulate MMP-13
protein expression in bones [8]. Calcitonin, on the
other hand, counteracts PTH by inhibiting osteo-
clasts activity [32]. We have treated mouse calvariae
with PTH in the absence or presence of calcitonin
and compared the resulting collagenolytic activity
with that of caseinolytic and gelatinolytic activities
in the extracts (Fig. 9). Whereas collagenolytic and
gelatinolytic activities signi¢cantly augmented with
increasing PTH concentrations and reached a plateau
at 1038 M PTH (Figs. 9A and 9B, casein degradation
did not change in response to PTH. The augmenta-
tion of Ca2 release by increasing PTH (Fig. 9C)
concentrations indicated that bone resorption had
occurred (Fig. 9D). Addition of 0.9 U/ml calcitonin
resulted in a signi¢cant decrease of extractable colla-
genolytic activity and in most cases also of gelatino-
lytic activity, whereas caseinolytic activity remained
unchanged. Ca2 release into the medium was
Fig. 8. MMP-13 and MMP-3 mRNA and protein expression in response to heparin. Ten mouse calvariae per experimental condition
were maintained in basal Eagle’s medium in the absence or presence of 33^300 Wg/ml heparin for 2 or 4 days. Conditioned media
were diluted with 1 vol. of loading bu¡er and 15 Wl was subjected either to gelatin (A), casein (B) and reverse (gelatin) (C) zymogra-
phies or to Western blots incubated with 1 Wg/ml anti-mouse MMP-13 (D) or MMP-3 (E) IgGs according to Section 2. RNase protec-
tion assays (F) were performed on total RNAs from 10 calvariae per experimental condition, maintained for 6 or 24 h in the absence
or presence of 300 Wg/ml heparin. Signal intensities, expressed in arbitrary units, are shown below the gels (G). St = molecular weight
standards.
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equally decreased indicating that bone resorption
had been inhibited by calcitonin. The observation
that calcitonin decreased the PTH-induced collage-
nolytic activity somewhat contrasts with the results
of Delaisse¤ et al. [8] who described that calcitonin
does not appreciably alter the e¡ect of PTH. How-
ever, whereas Delaisse¤ et al. used fetal mice calvariae,
our experiments were performed with calvariae from
newborn mice. As previously observed, culturing cal-
variae slightly, but signi¢cantly, increased collageno-
lytic and caseinolytic activities (P6 0.05 in Fig. 9A,
P6 0.017 in Fig. 9C); still, gelatinolytic activities
were equal in non-cultured calvariae and cultured
calvariae (Fig. 9B).
Whereas the collagenolytic activity in Fig. 9A was
speci¢c for MMP-13, the gelatinolytic activity seen in
Fig. 9B and the caseinolytic activity in Fig. 9C could
also be partially due to other enzymes such as MMP-
2, MMP-9 or MMP-3. We therefore further charac-
terized the extracts from PTH-treated calvariae and
performed reverse (gelatin) zymographies and casein
zymographies after treatment of the samples with
loading bu¡er without or with 50 mM DTT (Fig.
10). The reverse (gelatin) zymography in Fig. 10A
shows in the absence of DTT that the levels of
MMP-2 (68 and 62 kDa) and of the active form of
MMP-9 (84 kDa) were increased in the presence of
5.1038 M PTH, regardless on whether 0.9 U/ml cal-
citonin was present or not. Similarly, TIMP-1 pro-
tein was low in non-cultured and cultured calvariae,
and increased upon addition of PTH in the absence
or presence of calcitonin. To enhance the visibility of
MMP-13, MMP-2, MMP-9 and TIMP-1 were inac-
tivated by treatment with 50 mM DTT. Such treat-
ment revealed that both the latent and the active
forms of MMP-13 augmented after treatment with
PTH in the absence or presence of calcitonin. Casein
zymography (Fig. 10B) showed that MMP-3 activity
was either absent or detected only at very low levels.
Interestingly, in non-cultured and to a lesser extent in
calvariae cultured without any addition, a caseino-
lytic activity was observed at 26 kDa. This 26 kDa
activity was inhibited if the sample had been treated
with loading bu¡er containing 50 mM DTT. By con-
Table 1
E¡ect of heparin on the MMPs concentrations in the medium
Conditions Enzyme assays
(U/ml)
ELISAs
(Wg/ml)
COL CAS GEL MMP-13 MMP-3
24 h C 0.73 0.00 0.22 1.729 1.525
+HEP 2.63 0.00 1.95 9.437 1.931
72 h C 1.36 0.27 2.42 1.789 2.195
+HEP 8.76 1.07 8.06 12.411 3.175
40 calvariae per experimental condition were maintained in cul-
tured for 24 or 72 h without (C) or with 300 Wg/ml heparin
(+HEP). At the end of each culture, conditioned media were
collected. All assays were performed after activation by 0.4 mM
APMA for 2 h at 25‡C. COL = collagenolytic activity measured
with the di¡use ¢bril assay; CAS = caseinolytic activity;
GEL = gelatinolytic activity.
Fig. 9. PTH-induced bone resorption parallels MMP-13 but not
MMP-3 production in mouse calvariae. Three calvariae per ex-
perimental condition were incubated for 3 days in the absence
or presence of 1039^1037 M PTH or 1037 M PTH plus 0.9 U/
ml of calcitonin and media were changed daily. Ca2 concentra-
tions were measured in each conditioned medium and the cu-
mulative values over 3 days are shown in relation to non PTH-
treated cultures (0 M PTH = 1) (D). At the end of the culture,
calvariae were extracted as detailed in Section 2. Collagenolytic
(A), gelatinolytic (B) and caseinolytic (C) activities were meas-
ured in the four sequential extracts and the sum of all four is
shown in relation to the non PTH-treated culture (0 M
PTH = 1). Values are means/calvarium þ standard deviation.
1 = 0.992 U in A, 0.528 U in B, 1.787 U in C and 25.2 Wg in
D. 0 NC = non-cultured calvariae; -7+CT = 1037 M PTH plus
0.9 U/ml of calcitonin; ND = not done; *Signi¢cant vs. 0 M
PTH (P6 0.05 or less). **Signi¢cant vs. 1037 M PTH (P6 0.01
or less).
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Fig. 10. PTH regulates MMP-13 but not MMP-3 mRNA and protein expression in mouse calvariae. Six calvariae per experimental
condition were incubated for 2 days without (C) or with 5.1038 M PTH in the absence (PTH) or presence of 0.9 U/ml calcitonin
(PTH+CT). Media were changed after 24 h. Cultured as well as non-cultured (NC) calvariae were then extracted twice and concen-
trated 10U. Both extracts were combined, diluted with 1 vol. of loading bu¡er in the absence (-DTT) or presence (+DTT) of 50 mM
DTT and 15 Wl was submitted to reverse (gelatin) (A) or casein zymography (B). Western blots of the same samples were incubated
with 5 Wg/ml anti-mouse MMP-13 IgGs (C) and 5 Wg/ml anti-mouse MMP-3 IgGs (D). RNase protection assays (E) were performed
on total RNAs extracted from 10 calvariae per experimental condition either non-cultured (NC) or maintained in culture without (C)
or with 5.1038 M PTH in the absence (PTH) or presence of 0.9 U/ml calcitonin (PTH+CT) for 6 h and 24 h. Arbitrary values of sig-
nal intensities (F) as well as Ca2 concentrations in the media (G) are given below the corresponding RNase protection assay. Wg/
calv =Wg/calvarium. *Signi¢cant vs. incubation condition without PTH (P6 0.0002). **Signi¢cant vs. culture with PTH alone
(P6 0.003). St = molecular weight standards.
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trast, the activity was not inhibited by 10 WM E-64,
1 mM AEBSF (aminoethyl benzenesulfonyl£uoride),
1 WM pepstatin, 10 mM 1,10-phenanthroline, or in
the absence of Ca2 and Zn2. Moreover, the activ-
ity on casein zymographies was stronger at pH 7.5
than at pH 5 and was absent at pH 10.3. Anti-mouse
MMP-3 IgGs did not react with proteins in the
26 kDa region on the Western blots. The signi¢cance
of this activity is not clear and we are currently fur-
ther characterizing this protein.
Fig. 10C and D show Western blots of non-cul-
tured and cultured calvariae in the absence or pres-
ence of PTH. MMP-13 levels were marginal in non-
cultured calvariae, became clearly visible in cultured
calvariae and were even higher in the presence of
PTH; addition of calcitonin did not alter PTH-in-
duced MMP-13 protein expression (Fig. 10C).
MMP-3 in Fig. 10D was not immunodetectable in
Western blots of extracts. In corresponding condi-
tioned media, MMP-3 was clearly detectable by
Western blotting, suggesting that the enzyme had al-
ready left the bone (data not shown).
The discrepancy between the lack of a calcitonin
e¡ect on MMP-13 expression in reverse (gelatin) zy-
mography (Fig. 10A) and in Western blots (Fig.
10C), and the pronounced e¡ects of this hormone
detected as lower activities in the corresponding col-
lagenolytic and gelatinolytic assays (Figs. 9A and
9B), is likely to be due to subtle increased TIMP
concentrations. However, this still has to be investi-
gated.
To analyze mRNA expression response to PTH,
RNase protection assays were performed after
6 and 24 h of calvariae cultures. MMP-3 mRNA
levels remained unchanged, regardless on whether
calvariae were non-cultured or cultured under vari-
ous conditions. By contrast, but in accordance with
the ¢ndings by Henriet et al. [33], MMP-13 mRNA
expression was at the level of detection in non-cul-
tured calvariae, but augmented when calvariae were
put in culture for 6 h or even more for 24 h. Fur-
thermore, addition of PTH in the absence or pres-
ence of calcitonin led to a strong increase of mRNA
levels. Whereas after 6 h Ca2 concentration in the
culture medium did not respond to PTH in the ab-
sence or presence of calcitonin, after 24 h of culture
addition of PTH let to doubling of Ca2 concentra-
tion, indicating that bone resorption was occurring.
Counter-regulation by calcitonin caused a complete
reversal of PTH-induced bone resorption.
Taken together, our experiments suggest that con-
ditioned media from newborn mouse calvariae con-
tain signi¢cant amount of MMP-13, MMP-3, MMP-
2, MMP-9 and TIMPs. It was shown that MMP-13
is responsible not only for all of the collagenolytic,
but also for most of the caseinolytic, gelatinolytic
and proteoglycanolytic activities measured in mouse
calvariae-conditioned media. Together with the ob-
servations of restricted MMP-13 expression during
fetal bone development in both rodents [34,35] and
humans [36,37], our data suggest that this enzyme
also plays an important role in the extracellular ma-
trix remodeling in newborn mice. However, its cellu-
lar localization (osteoblasts, osteoclasts) is still the
object of debate [34^38]. Furthermore, we demon-
strated that in vitro PTH-induced bone resorption
is associated with an increase of MMP-13, but not
MMP-3, mRNA and protein expression. However,
the inhibitory e¡ect of calcitonin on bone resorption
is not due to a change in MMP-13 or MMP-3 ex-
pression, suggesting a di¡erent mode of action for
this counter-regulatory hormone.
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